352 followers
2,897 followers
There is currently an unmet need for new #NTMPD treatments. Check out this paper co-authored by our CMO Dr. Kamal Hamed titled "Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720" discussing the challenges in managing NTM-PD: h
2,897 followers
Our CMO, Kamal Hamed, MD, MPH, MBA, co-authored a peer-reviewed paper highlighting the potential of the oral antibiotic treatment we're developing for #NMTPD. Learn about the recent expansion of preclinical data associated with our potential therapy here: